Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Glaxo announces plans to launch five new vaccines
The company revealed details about the new drugs when it was updating investors and financial analysts on its vaccines division. GlaxoSmithKline said its Cervarix product for the prevention
The company revealed details about the new drugs when it was updating investors and financial analysts on its vaccines division. GlaxoSmithKline said its Cervarix product for the prevention
Under the terms of the agreement, Novartis will undertake most of the further development and all commercialization activity for the compound which is currently undergoing phase II clinical
The company is said to have ended the partnership after a study revealed that the drug Daxas, an oral anti-inflammatory product, was not as effective as the two
According to the company, patients receiving Seroquel showed a statistically significant decrease in depression scores compared to patients taking placebo throughout the eight-week study. About 58% of the
Pharming has agreed to license AgReasearch its proprietary protein production technology, giving AgResearch responsibility for compound production, including the initial financing of the development program. AgResearch will also
The company had hoped that the phase III trial would prove Hyphanox to be as effective as the leading treatment for vaginal candidiasis, commonly known as vaginal yeast
Rotateq is an oral liquid vaccine that contains five human serotypes which cause most rotavirus disease worldwide. Zostavax is Merck’s investigational vaccine for the prevention of herpes zoster
The large-scale study conducted by Roche compared Pegasys to GlaxoSmithKline’s lamivudine to show that Pegasys can offer greater symptom improvement to patients with the most common form of
The FDA issued a non-approvable letter to Penwest in response to the company’s application to market PW2101 as a treatment of hypertension and angina. The reasons behind the
Obstructive sleep apnea (OSA) is a common breathing disorder which affects 15 to 20 million people in the US alone. The condition is characterized by brief interruptions in